Brickell Biotech Inc reports results for the quarter ended in September - Earnings Summary

Fresh Tracks Therapeutics

09/11/2021 22:50

* Brickell Biotech Inc  BBI.OQ  reported a quarterly adjusted
loss of 16 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 12 cents per share.
* Revenue fell 7% to $132.00 thousand from a year ago;  analysts
expected $150.00 thousand. 
* Brickell Biotech Inc's reported EPS for the quarter was a loss
of 16 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Brickell Biotech Inc shares had fallen by 44.4% this
quarter and lost 48.8% so far this year.
* The company reported a quarterly loss of $13.25 million.
* Wall Street's median 12-month price target for Brickell
Biotech Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 10:50 p.m.
 ​All figures in US dollars unless otherwise stated